scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10549-015-3520-2 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1007/s10549-015-3520-2 |
P698 | PubMed publication ID | 26227474 |
P5875 | ResearchGate publication ID | 280583241 |
P50 | author | Kara L. Britt | Q37370390 |
Erik W. Thompson | Q37829135 | ||
John Hopper | Q56726496 | ||
P2093 | author name string | D Huang | |
G L Chew | |||
M A Henderson | |||
P Hill | |||
J Cawson | |||
I Haviv | |||
C W Huo | |||
H Frazer | |||
P2860 | cites work | Dynamic changes in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers during various murine peripartum states and over time | Q57305981 |
Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue | Q57305995 | ||
Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control Study | Q59288218 | ||
Aspirin intake and survival after breast cancer | Q24604280 | ||
Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention | Q28193249 | ||
NSAIDs and breast cancer recurrence in a prospective cohort study | Q28221965 | ||
Nonsteroidal anti-inflammatory drugs and change in mammographic density: a cohort study using pharmacy records on over 29,000 postmenopausal women | Q33811534 | ||
Collagen density promotes mammary tumor initiation and progression | Q33845553 | ||
COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment | Q33877411 | ||
Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. | Q34206453 | ||
Mammographic density and breast cancer risk: current understanding and future prospects | Q34235753 | ||
Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. | Q35586182 | ||
Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression | Q35735316 | ||
High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium | Q35797147 | ||
Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis | Q36507079 | ||
Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
Breast cancer and NSAID use: a meta-analysis | Q36622959 | ||
Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival | Q36649103 | ||
A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer | Q36903254 | ||
Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer | Q36916765 | ||
Tissue composition of mammographically dense and non-dense breast tissue | Q36999585 | ||
No effect of aspirin on mammographic density in a randomized controlled clinical trial | Q37210539 | ||
Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density | Q37400742 | ||
Preventive therapy for breast cancer: a consensus statement | Q37858249 | ||
Mammographic density-a review on the current understanding of its association with breast cancer | Q38194952 | ||
Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. | Q38291062 | ||
COX-2 promotes breast cancer cell radioresistance via p38/MAPK-mediated cellular anti-apoptosis and invasiveness | Q39138862 | ||
High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers | Q39597471 | ||
The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. | Q44406183 | ||
Cyclooxygenase-2 expression in proliferative Ki-67-positive breast cancers is associated with poor outcomes. | Q53389613 | ||
COX-2 is expressed in human pulmonary, colonic, and mammary tumors. | Q53402915 | ||
Effects of Tamoxifen and oestrogen on histology and radiographic density in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers. | Q53408150 | ||
Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta. | Q54108530 | ||
Associations of mammographic dense and nondense areas and body mass index with risk of breast cancer. | Q54679615 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | xenograft | Q64148587 |
P304 | page(s) | 89-99 | |
P577 | publication date | 2015-07-31 | |
P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
P1476 | title | Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density. | |
P478 | volume | 153 |
Q92282046 | Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer |
Q55117383 | An overview of mammographic density and its association with breast cancer. |
Q37579197 | CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model. |
Q58793402 | High mammographic density in women is associated with protumor inflammation |
Q59799817 | Mammographic density and breast tissue expression of inflammatory markers, growth factors, and vimentin |
Q28074177 | Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies |
Q50214824 | Pre-clinical effects of metformin and aspirin on the cell lines of different breast cancer subtypes. |
Q28066162 | Stromal characteristics may hold the key to mammographic density: the evidence to date |
Search more.